European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - gamithromycin - antibacterials for systemic use - cattle; pigs; sheep - cattletreatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni. the presence of the disease in the herd should be established before metaphylactic use.pigstreatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and bordetella bronchiseptica.sheeptreatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

boehringer ingelheim vetmedica gmbh - gamithromycin - solution for injection - antimicrobial - cattle, pigs, sheep

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merial, france - gamithromycin - solution for injection - 150 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merial, france - gamithromycin - solution for injection - 150 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merial, france - gamithromycin - solution for injection - 150 mg/ml

Israel - English - Ministry of Health

beit-erez havat milatin ltd - gamithromycin - solution for injection - gamithromycin 150 mg/ml - * cattle: therapeutic and preventive treatment (metaphylaxis) of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni.the presence of the disease in the herd should be established before preventive treatment. * pigs (swine): treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida and haemophilus parasuis. * sheep:treatment of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus and fusobacterium necrophorum requiring systemic treatment.